Innovative process engineering to customize biopharmaceutical manufacturing.

As a world class CDMO facility, we offer small, pilot and large-scale drug substance capacities for clinical and commercial use across mammalian, microbial and viral vector platforms with flexibility to adopt to various other modalities such as cell and gene therapy, etc. We have demonstrated ability to build world-class facilities compliant with global regulatory standards with industry leading timelines. Our development and manufacturing teams are highly experienced in tech transfer, scale-up and validation of biopharmaceutical drug substance processes.